☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Ebola Virus Disease
Merck's Ervebo [Ebola Zaire Vaccine (rVSVΔG-ZEBOV-GP) live] Receives EC's Conditional Approval to Prevent Ebola Virus Disease
November 12, 2019
Janssen Reports Submission of MAA to EMA for its Investigational Ebola Vaccine Regimen to Prevent Ebola Virus Disease
November 8, 2019
Merck's V920 Ebola Zaire Vaccine Receives CHMP Positive Opinion to Protect Against Ebola Virus Disease
October 18, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.
![Merck's Ervebo [Ebola Zaire Vaccine (rVSVΔG-ZEBOV-GP) live] Receives EC's Conditional Approval to Prevent Ebola Virus Disease](https://pharmashots.com/public/default-image/default-358x215.png )
